LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS)
$0.065 0 (0%)
Analysed LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS) News Sources
Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
12-05-2026
yahoo.com
Ligand Pharmaceuticals' (NASDAQ:LGND) Strong Earnings Are Of Good Quality
15-05-2026
yahoo.com
Is WaterBridge Stock a Buy After Ranger Investment Raised Its Stake by 345,000 Shares?
16-05-2026
fool.com
Is Genpact Stock a Buy After Hedge Fund Rice Hall James Raised Its Stake by $14 Million?
19-05-2026
fool.com
Ligand to Participate in June Investor Conferences
27-05-2026
yahoo.com
OneSpaWorld Posted Record Revenue for Last Quarter. Why Did a Fund Exit a $21.5 Million Stake?
29-05-2026
fool.com
Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy?
30-05-2026
fool.com
How The Ligand Pharmaceuticals (LGND) Investment Story Is Evolving Without Fresh Analyst Targets
01-06-2026
yahoo.com
A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million
07-06-2026
fool.com
Ligand Announces 2026 Investor Day in New York City
10-06-2026
yahoo.com
What is the current price of LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS)?
The current price of LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS) is $0.065.
LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS) absolute price change since previous trading day?
The absolute price change of LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS) since the previous trading day is $0.
LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS) percentage price change since previous trading day?
The percentage price change of LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS)?
The most recent average sentiment score for LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS) is 76 out of 100.
What is the most recent average sentiment for LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS)?
The most recent sentiment for LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS) is .
SEC-8K** Filing Available For LIGAND PHARMA-TR BETA CVR (LGNZZ:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.